Erica A. Roesch

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ≥6 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A Phase 3, Open-Label Clinical Trial

Claire Wainwright, Susanna A. McColley, Paul McNally et al. · American Journal of Respiratory and Critical Care Medicine · 2023 · 65 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +14

Quantitative CT Characteristics of Cluster Phenotypes in the Severe Asthma Research Program Cohorts

Abhaya Trivedi, Chase Hall, Charles W. Goss et al. · Radiology · 2022 · 31 citations · Full text

Medicine, Clinical Sciences, Radiology +17

A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosis

Erica A. Roesch, Tracey L. Bonfield, Hillard M. Lazarus et al. · Journal of Cystic Fibrosis · 2022 · 23 citations

Medicine, Immunology, Cell Therapy +11

[Report of experiences in the treatment of 16 cases of severe glycoside poisoning with digitalis antibody fragments (Fab)].

A. Smolarz, Erica A. Roesch, H Lenz et al. · PubMed · 1984 · 16 citations

Pharmacy, Clinical Toxicology, Toxicology +5

Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks

Shuyu Hao, Erica A. Roesch, Aura Perez et al. · Journal of Cystic Fibrosis · 2019 · 16 citations

Life Sciences, Molecular Biology, Molecular Genetics +16